Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2014, Article ID 641587, 5 pages
http://dx.doi.org/10.1155/2014/641587
Research Article

High Salt Intake Increases Copeptin but Salt Sensitivity Is Associated with Fluid Induced Reduction of Copeptin in Women

1Department of Internal Medicine, Skåne University Hospital, 20502 Malmö, Sweden
2Department of Clinical Sciences, Lund University, 20502 Malmö, Sweden

Received 8 September 2014; Accepted 8 October 2014; Published 23 October 2014

Academic Editor: Franco Veglio

Copyright © 2014 Irina Tasevska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. P. Midgley, A. G. Matthew, C. M. T. Greenwood, and A. G. Logan, “Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials,” Journal of the American Medical Association, vol. 275, no. 20, pp. 1590–1597, 1996. View at Publisher · View at Google Scholar · View at Scopus
  2. J. A. Cutler, D. Follmann, and P. Scott Allender, “Randomized trials of sodium reduction: an overview,” The American Journal of Clinical Nutrition, vol. 65, no. 2, pp. 643S–651S, 1997. View at Google Scholar · View at Scopus
  3. N. A. Graudal, A. M. Galløe, and P. Garred, “Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis,” The Journal of the American Medical Association, vol. 279, no. 17, pp. 1383–1391, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. F. J. He and G. A. MacGregor, “Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health,” Journal of Human Hypertension, vol. 16, no. 11, pp. 761–770, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. M. R. Law, C. D. Frost, and N. J. Wald, “By how much does dietary salt reduction lower blood pressure? III—Analysis of data from trials of salt reduction,” British Medical Journal, vol. 302, no. 6780, pp. 819–824, 1991. View at Publisher · View at Google Scholar · View at Scopus
  6. F. M. Sacks, L. P. Svetkey, W. M. Vollmer et al., “Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group,” The New England Journal of Medicine, vol. 344, no. 1, pp. 3–10, 2001. View at Google Scholar
  7. J. Dahlberg, L.-O. Nilsson, F. von Wowem, and O. Melander, “Polymorphism in NEDD4L is associated with increased salt sensitivity, reduced levels of P-renin and increased levels of Nt-proANP,” PLoS ONE, vol. 2, no. 5, article no. e432, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Enhörning, J. Struck, E. Wirfält, B. Hedblad, N. G. Morgenthaler, and O. Melander, “Plasma copeptin, a unifying factor behind the metabolic syndrome,” The Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 7, pp. E1065–E1072, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Enhörning, L. Bankir, N. Bouby et al., “Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö diet and cancer study cardiovascular cohort,” International Journal of Obesity, vol. 37, no. 4, pp. 598–603, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Enhörning, T. J. Wang, P. M. Nilsson et al., “Plasma copeptin and the risk of diabetes mellitus,” Circulation, vol. 121, no. 19, pp. 2102–2108, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Struck, N. G. Morgenthaler, and A. Bergmann, “Copeptin, a stable peptide derived from the vasopressin precursor, is elevated in serum of sepsis patients,” Peptides, vol. 26, no. 12, pp. 2500–2504, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Fenske, C. Wanner, B. Allolio et al., “Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus,” Journal of the American Society of Nephrology, vol. 22, no. 4, pp. 782–790, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. N. S. Stachenfeld, A. E. Splenser, W. L. Calzone, M. P. Taylor, and D. L. Keefe, “Genome and hormones: gender differences in physiology selected contribution: sex differences in osmotic regulation of AVP and renal sodium handling,” Journal of Applied Physiology, vol. 91, no. 4, pp. 1893–1901, 2001. View at Google Scholar · View at Scopus
  14. M. Hammar, G. Berg, L. Fahraeus, and U. Larsson-Cohn, “Climacteric symptoms in an unselected sample of Swedish women,” Maturitas, vol. 6, no. 4, pp. 345–350, 1984. View at Publisher · View at Google Scholar · View at Scopus